Merck wins first FDA approval for Keytruda as a treatment for mesothelioma

Merck & Co. Inc. said Wednesday that the US Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for multiple malignant mesothelioma, a rare cancer associated with asbestos.